Nonalcoholic Fatty Liver Disease in Canadian First Nations and Non-First Nations Patients by Julia Uhanova, Gerald Minuk, Federico Lopez Ficher, Natasha Chandok

“…Features of nonalcoholic fatty liver disease (NAFLD) have yet to be described in the Canadian First Nations (FN) population. …”
Get full text

Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality by Rosa Oh, Seohyun Kim, So Hyun Cho, Jiyoon Kim, You-Bin Lee, Sang-Man Jin, Kyu Yeon Hur, Gyuri Kim, Jae Hyeon Kim

“…Background Given the association between nonalcoholic fatty liver disease and metabolic risks, a new term, metabolic dysfunction-associated steatotic liver disease (MASLD) has been proposed. …”
Get full text

Comment on “Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp” by Davide Giuseppe Ribaldone, Giorgio Maria Saracco, Rinaldo Pellicano

Get full text

Zinc Monotherapy as an Alternative Treatment Option for Decompensated Liver Disease due to Wilson Disease? by Hansa Haftu, Mohammed Mustefa, Teklu Gebrehiwot

“…Zinc monotherapy with low copper diet was initiated for decompensated liver disease due to Wilson disease because of the inaccessibility of chelators (D-penicillamine or Trientine). …”
Get full text

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment by Ye. N. Shirokova

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Systematic review of exercise for the treatment of pediatric metabolic dysfunction-associated steatotic liver disease. by Martha R Smith, Elizabeth L Yu, Ghattas J Malki, Kimberly P Newton, Nidhi P Goyal, Karen M Heskett, Jeffrey B Schwimmer

“…<h4>Background & aims</h4>Steatotic liver disease affects approximately 1 in 10 children in the U.S. and increases the risk of cirrhosis, diabetes, and cardiovascular disease. …”
Get full text

The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease by Sun Xin, Zhang Yan, Xie Meilin

Subjects: “…non alcoholic fatty liver disease…”
Get full text

Role of Toll-Like Receptors and Their Downstream Molecules in the Development of Nonalcoholic Fatty Liver Disease by Kouichi Miura, Ekihiro Seki, Hirohide Ohnishi, David A. Brenner

“…Activation of innate immunity is associated with the development of liver disease, including non-alcoholic fatty liver disease (NAFLD). …”
Get full text

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease” by Stefano Bibbò, Maria Pina Dore, Giovanni Cammarota

Get full text

Associations between Extracellular Matrix Protein 1 Gene Polymorphism and Progression of Liver Disease by Xiuting He, Ting Liu, Rui Zhang, Xu Li

Get full text

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus by A. E. Bagriy, A. D. Zubov, M. V. Khomenko, E. S. Mikhailichenko, E. A. Pylaeva, N. A. Khaustova, E. V. Bryukhovetskaya

Subjects: “…non-alcoholic fatty liver disease…”
Get full text

Rare forms of nonalcoholic fatty liver disease: hereditary lysosomal acid lipase deficiency by M. V. Mayevskaya, V. T. Ivashkin, M. S. Zharkova, T. P. Nekrasova, G. I. Ayusheva, R. V. Maslennikov

“…To acquaint general practitioners with a rarely diagnosed disease - the hereditary deficiency of lysosomal acid lipase (DLAL) which can develop under the «mask» non-alcoholic fatty liver disease (NAFLD). Summary. There are two forms of DLAL clinical manifestations: as fulminant lethal Wolman disease and slowly progressing cholesterol ethers storage disease (CESD). …”
Get full text

The Utility of Xenon-133 Liver Scan in the Diagnosis and Management of Nonalcoholic Fatty Liver Disease by Said A Al-Busafi, Peter Ghali, Philip Wong, Javier A Novales-Diaz, Marc Deschênes

“…Nonalcoholic fatty liver disease (NAFLD) encompasses a wide spectrum of liver damage and is the most common cause of chronic liver diseases in Western countries. …”
Get full text

The Predictive Role of Parathyroid Hormone for Nonalcoholic Fatty Liver Disease following Bariatric Surgery by Tannaz Jamialahmadi, Mohsen Nematy, Mohammed Abdalla, Ali Jangjoo, Ladan Goshayeshi, Matthew Kroh, Seyed Adel Moallem, Mitra Abbasifard, Thozhukat Sathyapalan, Amirhossein Sahebkar

“…Morbid obesity is frequently complicated by chronic liver diseases, including nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and fibrosis. …”
Get full text

Increasing Whole Grain Intake as Part of Prevention and Treatment of Nonalcoholic Fatty Liver Disease by Alastair B. Ross, Jean-Philippe Godin, Kaori Minehira, John P. Kirwan

“…Due to their nutrient and phytochemical composition, switching from consuming mainly refined grains to whole grains should be considered as part of the nutritional guidelines for patients diagnosed with or at risk for fatty liver disease.…”
Get full text

Distribution of culture-positive microorganisms varies with severity of liver disease in patients hospitalized with SBP by Nadim Mahmud, Natalia Salinas Parra, Aaron L. Hecht, David E. Kaplan, Marina Serper

Get full text

The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review by Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, Amirhossein Sahebkar

“…Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that can lead to end-stage liver disease needing a liver transplant. …”
Get full text

Regulation of Hippo-YAP1/TAZ pathway in metabolic dysfunction-associated steatotic liver disease by Wei Xuan, Dandan Song, Jianghua Hou, Xiuping Meng

“…Metabolic dysfunction-associated steatotic liver disease (MASLD) has become the most prevalent chronic liver disease worldwide, but effective treatments are still lacking. …”
Get full text

Increased platelet aggregation in hepatic tissue of metabolic-associated fatty liver disease—an observational study by Rongshan Fan, Yandong Li, Zeng Du

Subjects: “…metabolic-associated fatty liver disease…”
Get full text

Pentraxin 3 Is a Predictor for Fibrosis and Arterial Stiffness in Patients with Nonalcoholic Fatty Liver Disease by Kadir Ozturk, Omer Kurt, Tolga Dogan, Alptug Ozen, Hakan Demirci, Fatih Yesildal, Murat Kantarcioglu, Turker Turker, Ahmet Kerem Guler, Yıldırım Karslioglu, Battal Altun, Ahmet Uygun, Sait Bagci

Get full text